US equities
|
TSLA
$391.62
▲+5.21%
MU
$903.67
▲+2.98%
NVDA
$216.02
▲+2.40%
META
$630.56
▼-1.88%
SPCX
$146.90
▼-0.40%
AAPL
$344.01
▼-1.07%
MSFT
$532.60
▲+1.54%
INTC
$90.52
▲+4.09%
TSLA
$391.62
▲+5.21%
MU
$903.67
▲+2.98%
NVDA
$216.02
▲+2.40%
META
$630.56
▼-1.88%
SPCX
$146.90
▼-0.40%
AAPL
$344.01
▼-1.07%
MSFT
$532.60
▲+1.54%
INTC
$90.52
▲+4.09%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Fusion Pharmaceuticals Inc
Recent news which mentions Fusion Pharmaceuticals Inc
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Investment strategy
Health care industry
AstraZeneca PLC
From
CNBC.com News